Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsacute-care-resuscitation-and-toxicology

Paeds SAQs · acute-care-resuscitation-and-toxicology

Humane restraint and behavioural support in emergency care — formative SAQs

Two MedVellum formative short-answer questions on the child with acute behavioural disturbance in the emergency department: ensuring safety and treating medical causes first, leading verbal de-escalation and environmental modification, offering oral medication with consent (supported by the PEAChY-O trial), escalating to parenteral rapid tranquillisation only when oral fails or is unsafe, reserving physical restraint for grave and imminent danger, monitoring every sedated child, and debriefing with the patient, family and team. The marks and timing support transparent self-assessment. They are not an official board format or pass standard.

20 marks30 min5 min readVerification in progress

Target exams

RACP General PaediatricsRACP DWERACP DCERCPCH Progress+MRCPCH TheoryMRCPCH ClinicalABP General PediatricsACGME PediatricsRCPSC Pediatrics
On this page
Study tools

Target exams

RACP General PaediatricsRACP DWERACP DCERCPCH Progress+MRCPCH TheoryMRCPCH ClinicalABP General PediatricsACGME PediatricsRCPSC Pediatrics
Prompt
SAQ 1 covers the immediate, team-led response to a seven-year-old with acute agitation, abnormal observations and no psychiatric history: ensuring safety, treating the medical cause first, de-escalation, the oral-first approach, and the decision to escalate. SAQ 2 covers severe agitation in an adolescent with methamphetamine intoxication, including the avoidance of olanzapine-benzodiazepine combinations, QT monitoring, physiological derangement, restraint as a last resort, and the mandatory post-event debrief and safeguarding review.

SAQ 1 (10 marks, 15 minutes)

Stem. A seven-year-old boy with no prior psychiatric history is brought to the emergency department acutely agitated after a two-day febrile illness. He is pacing the cubicle, cannot engage in conversation, and has just thrown a cup at a nurse. Observations: temperature 38.9 degrees Celsius, heart rate 150, respiratory rate 32, SpO2 92 percent in room air, capillary refill 2 seconds. Bedside glucose 3.2 millimoles per litre. His mother is present and frightened.

[1]

Task. Outline your immediate, team-led response over the next 30 minutes, including how you would ensure safety, the order of your clinical priorities, the role of de-escalation, your pharmacological approach with rationale, and the circumstances under which you would escalate to physical restraint.

[1]

Model answer

Safety and team (1 mark). Ensure the safety of staff, the child and others first: clear the cubicle of hazards and other patients, ensure the exit is clear, call for senior paediatric and nursing help, name a team leader, assign roles, and prepare monitoring and emergency equipment. [1]

Treat medical causes first (3 marks). The abnormal observations (fever, tachycardia, tachypnoea, SpO2 92 percent) and the borderline-low glucose in a young child with no psychiatric history make a medical cause the most likely driver of the agitation. Apply high-flow oxygen immediately for the hypoxia. Treat the borderline-low glucose with oral glucose if the child can swallow safely, or 2 to 5 millilitres per kilogram of 10 percent glucose intravenously if not; recheck. Send a septic screen and give empiric antibiotics and aciclovir if meningitis or encephalitis is suspected. Treat pain. The agitation is highly likely to settle as the hypoxia and the underlying illness are treated; sedating through the deterioration would mask the medical child. [1]

De-escalation and environment (2 marks). In parallel, a calm lead clinician at eye level, one voice, low-stimulation room with reduced light and noise, mother present if safe, offer a drink, and remove clinical uniforms and equipment that signal threat. A genuine trial of de-escalation runs alongside the medical work-up, not after it. [1]

Pharmacological approach (3 marks). Oral medication offered with consent as the first pharmacological step; the PEAChY-O randomised controlled trial supports oral as effective first-line. Olanzapine orally disintegrating tablet at an age-appropriate dose, or diazepam, are reasonable choices once the airway and glucose are secure. Parenteral rapid tranquillisation is reserved for refusal, safety concern, or failure of oral, with close monitoring for respiratory depression and QT effects. Because he is febrile and hypoxic, the threshold for parenteral sedation is higher (respiratory risk) and the work-up for a medical cause is the priority. [3] [4] [1]

Escalation to physical restraint (1 mark). Physical restraint is reserved for grave and imminent danger that cannot be prevented any other way: minimum force, minimum duration, trained team with a named leader, airway visible at all times, never face-down or in a hobble, reassessed at least every 15 minutes, documented and debriefed. A safeguarding review is automatic for any unexplained or repeated restraint. [1] [7]


Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References7ShowHide
  1. [1]Hilt RJ, Woodward TA Agitation treatment for pediatric emergency patients Journal of the American Academy of Child and Adolescent Psychiatry, 2008.PMID 18216715
  2. [3]Bourke EM, Borland ML, Kochar A, et al. Pharmacological emergency management of agitation in children and young people: protocol for a randomised controlled trial of oral medication (PEAChY-O) BMJ Open, 2023.PMID 36997250
  3. [4]Bourke EM, Kochar A, Shellshear D, et al. PEAChY-O: Pharmacological Emergency Management of Agitation in Children and Young People: A Randomized Controlled Trial of Oral Medication Annals of Emergency Medicine, 2025.PMID 39955661
  4. [7]Malashock HR, Yeung C, Roberts AR, et al. Pediatric Methamphetamine Toxicity: Clinical Manifestations and Therapeutic Use of Antipsychotics-One Institution's Experience Journal of Medical Toxicology, 2021.PMID 33442836
  5. [8]Hilt RJ Editorial: Best Practices in Child Antipsychotic Use Monitoring Journal of the American Academy of Child and Adolescent Psychiatry, 2021.PMID 33176169
  6. [9]Scott JP, Stuth EA, Stucke AG, et al. Droperidol transiently prolongs the QT interval in children undergoing single ventricle palliation Pediatric Cardiology, 2015.PMID 25087057
  7. [11]Menard ML, Thümmler S, Giannitelli M, et al. Incidence of adverse events in antipsychotic-naive children and adolescents treated with antipsychotic drugs: Results of a multicenter naturalistic study (ETAPE) European Neuropsychopharmacology, 2019.PMID 31699516
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousHeat illness, hypothermia and environmental emergencies — formative SAQsacute-care-resuscitation-and-toxicologyNextHydrocarbon, caustic and household chemical exposure — formative SAQsacute-care-resuscitation-and-toxicology